Various strategies might be considered to improve current chemotherapy regimens, such as simultaneous use of chemotherapy and antiviral agents, addition of a proteasome inhibitor or other agent to overcome NFκB-induced chemotherapy resistance [35], [36], or p53 inactivation in tumor cells [37]. Here, TP53 is linked to neoplasm.